Pioneer of drug discovery data management software recognized for his contribution to the industry

Guildford, United Kingdom, September 2005 – IDBS is proud to announce that Neil Kipling, founder, CEO and Chairman of the company, has been formally recognized for his contribution to the art and science of drug discovery. The 2005 SBS Accomplishment Award for Innovation in Information Management for Scientific Software was awarded to Kipling at the 11th Annual SBS Conference and Exhibition, September 11-15, 2005 in Geneva, Switzerland.
 

Founded in 1989, the company today is a premier supplier of solutions for drug discovery data management. Its flagship product, ActivityBase, continues to be the established industry standard, whilst the company’s latest offering, BioBook, promises to be a best of class electronic lab notebook designed specifically for biologists. IDBS currently serves over 200 discovery organisations worldwide and is committed to customer satisfaction, with over 70% of its staff dedicated to R&D and customer support activities.

Upon accepting the award, Kipling said, “I feel very honored to have been recognized for the contribution that IDBS has made to the drug discovery industry. We (IDBS) have a long heritage in the drug discovery informatics arena, and will continue to innovate. It is extremely gratifying that such a prestigious institute as SBS has acknowledged this effort.”

Dr. Dejan Bojanic, President of SBS said, “The Society for Biomolecular Screening provides a forum for education and information exchange among professionals within drug discovery and related disciplines. We believe that individuals making a significant contribution to the furtherance of drug discovery should be acknowledged. In this spirit, I am delighted that this years award be given to Neil Kipling.”

In addition to the award, Kipling’s achievement will also be recognised in the Journal of Biomolecular Screening and with a $1000 honorarium. Kipling said, “It is my intention to donate the honorarium to The Sunflower Trust – a charitable organization dedicated to helping children with learning difficulties based in Guildford, where IDBS is headquartered.”

About IDBS
IDBS is a leading provider of integrated software solutions to the life sciences industry. Maximizing the value of research data by enabling organisations to capture, store, share and use data efficiently and effectively, whilst protecting intellectual property across the spectrum of discovery activities.

Headquartered in Guildford, UK, IDBS has U.S. offices in California, New Jersey and Massachusetts. IDBS partners with CTC Laboratory Systems in Japan and a network of distributors to market IDBS products and services in Asia. Founded in 1989, IDBS employs more than 150 people worldwide. For more information, visit: http://www.idbs.com.


About The Society for Biomolecular Screening is a not-for-profit organization dedicated to advancing the science of drug discovery internationally. As the sole organization supporting high-throughput-screening and related disciplines, SBS provides a unique forum for education and information exchange. SBS’s official publication, The Journal of Biomolecular Screening, is a highly regarded reference for cutting edge research. The SBS Endowment Fund Small Grants program annually presents $25,000 to worthy recipients. Visit the SBS website: www.sbsonline.org